Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9775393rdf:typepubmed:Citationlld:pubmed
pubmed-article:9775393lifeskim:mentionsumls-concept:C0002395lld:lifeskim
pubmed-article:9775393lifeskim:mentionsumls-concept:C0007776lld:lifeskim
pubmed-article:9775393lifeskim:mentionsumls-concept:C0934502lld:lifeskim
pubmed-article:9775393lifeskim:mentionsumls-concept:C0206116lld:lifeskim
pubmed-article:9775393lifeskim:mentionsumls-concept:C0022655lld:lifeskim
pubmed-article:9775393lifeskim:mentionsumls-concept:C0001613lld:lifeskim
pubmed-article:9775393lifeskim:mentionsumls-concept:C0228174lld:lifeskim
pubmed-article:9775393lifeskim:mentionsumls-concept:C0333463lld:lifeskim
pubmed-article:9775393lifeskim:mentionsumls-concept:C1704711lld:lifeskim
pubmed-article:9775393lifeskim:mentionsumls-concept:C1522492lld:lifeskim
pubmed-article:9775393pubmed:issue4lld:pubmed
pubmed-article:9775393pubmed:dateCreated1998-12-7lld:pubmed
pubmed-article:9775393pubmed:abstractTextActivated microglia overexpressing interleukin-1 (IL-1) are prominent neuropathological features of Alzheimer's disease. We used computerized image analysis to determine the number of IL-1 alpha-immunoreactive (IL-1 alpha +) microglia in cytoarchitectonic layers of parahippocampal gyrus (Brodmann's area 28) of Alzheimer and control patients. For cortical layers I and II, the numbers of IL-1 alpha + microglia were similar in Alzheimer and control patients. For layers III-VI, the numbers of IL-1 alpha + microglia were higher than that seen in layers I-II for both Alzheimer and control patients. Moreover, for layers III-VI, the number of IL-1 alpha + microglia in Alzheimer patients was significantly greater than that in control patients (relative Alzheimer values of threefold for layer III-V and twofold for layer VI; P < 0.05 in each case). The cortical laminar distribution of IL-1 alpha + microglia in Alzheimer patients correlated with the cortical laminar distribution of beta-amyloid precursor protein-immunoreactive (beta-APP+) neuritic plaques found in Alzheimer patients (r = 0.99, P < 0.005). Moreover, the cortical laminar distribution of IL-1 alpha + microglia in control patients also correlated with the cortical laminar distribution of beta-APP+ neuritic plaques found in Alzheimer patients (r = 0.91, P < 0.05). These correlations suggest that pre-existing laminar distribution patterns of IL-1 alpha + microglia (i.e. that seen in control patients) are important in determining the observed laminar distribution of beta-APP+ neuritic plaques in Alzheimer patients. These findings provide further support for our hypothesis that IL-1 is a key driving force in neuritic plaque formation in Alzheimer's disease.lld:pubmed
pubmed-article:9775393pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9775393pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9775393pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9775393pubmed:languageenglld:pubmed
pubmed-article:9775393pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9775393pubmed:citationSubsetIMlld:pubmed
pubmed-article:9775393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9775393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9775393pubmed:statusMEDLINElld:pubmed
pubmed-article:9775393pubmed:monthAuglld:pubmed
pubmed-article:9775393pubmed:issn0305-1846lld:pubmed
pubmed-article:9775393pubmed:authorpubmed-author:GriffinW SWSlld:pubmed
pubmed-article:9775393pubmed:authorpubmed-author:MrakR ERElld:pubmed
pubmed-article:9775393pubmed:authorpubmed-author:RoystonM CMClld:pubmed
pubmed-article:9775393pubmed:authorpubmed-author:ShengJ GJGlld:pubmed
pubmed-article:9775393pubmed:issnTypePrintlld:pubmed
pubmed-article:9775393pubmed:volume24lld:pubmed
pubmed-article:9775393pubmed:ownerNLMlld:pubmed
pubmed-article:9775393pubmed:authorsCompleteYlld:pubmed
pubmed-article:9775393pubmed:pagination278-83lld:pubmed
pubmed-article:9775393pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:9775393pubmed:meshHeadingpubmed-meshheading:9775393-...lld:pubmed
pubmed-article:9775393pubmed:meshHeadingpubmed-meshheading:9775393-...lld:pubmed
pubmed-article:9775393pubmed:meshHeadingpubmed-meshheading:9775393-...lld:pubmed
pubmed-article:9775393pubmed:meshHeadingpubmed-meshheading:9775393-...lld:pubmed
pubmed-article:9775393pubmed:meshHeadingpubmed-meshheading:9775393-...lld:pubmed
pubmed-article:9775393pubmed:meshHeadingpubmed-meshheading:9775393-...lld:pubmed
pubmed-article:9775393pubmed:meshHeadingpubmed-meshheading:9775393-...lld:pubmed
pubmed-article:9775393pubmed:meshHeadingpubmed-meshheading:9775393-...lld:pubmed
pubmed-article:9775393pubmed:meshHeadingpubmed-meshheading:9775393-...lld:pubmed
pubmed-article:9775393pubmed:meshHeadingpubmed-meshheading:9775393-...lld:pubmed
pubmed-article:9775393pubmed:meshHeadingpubmed-meshheading:9775393-...lld:pubmed
pubmed-article:9775393pubmed:meshHeadingpubmed-meshheading:9775393-...lld:pubmed
pubmed-article:9775393pubmed:year1998lld:pubmed
pubmed-article:9775393pubmed:articleTitleDistribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease.lld:pubmed
pubmed-article:9775393pubmed:affiliationGeriatric Research, Education and Clinical Center, University of Arkansas for Medical Sciences, Little Rock, USA.lld:pubmed
pubmed-article:9775393pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9775393pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9775393lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9775393lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9775393lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9775393lld:pubmed